Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051401-04
Application #
2228130
Study Section
Special Emphasis Panel (ZRG7-SSS-1)
Project Start
1994-01-01
Project End
1998-04-30
Budget Start
1995-09-12
Budget End
1998-04-30
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Hauck, W W; Hyslop, T; Anderson, S (2000) Generalized treatment effects for clinical trials. Stat Med 19:887-99
Hauck, W W; Tozer, T N; Anderson, S et al. (1998) Considerations in the attainment of steady state: aggregate vs. individual assessment. Pharm Res 15:1796-8
Hauck, W W; Anderson, S; Marcus, S M (1998) Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials 19:249-56
Hauck, W W; Hauschke, D; Diletti, E et al. (1997) Choice of student's t- or Wilcoxon-based confidence intervals for assessment of average bioequivalence. J Biopharm Stat 7:179-89
Hauck, W W; Preston, P E; Bois, F Y (1997) A group sequential approach to crossover trials for average bioequivalence. J Biopharm Stat 7:87-96
Hauck, W W; Bois, F Y; Hyslop, T et al. (1997) A parametric approach to population bioequivalence. Stat Med 16:441-54
Anderson, S; Hauck, W W (1996) The transitivity of bioequivalence testing: potential for drift. Int J Clin Pharmacol Ther 34:369-74
Hauck, W W; Anderson, S (1994) Measuring switchability and prescribability: when is average bioequivalence sufficient? J Pharmacokinet Biopharm 22:551-64